Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey V Ravetch

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Biotechniques|March 12, 2008
Closing the circle. Jeffrey V. Ravetch, M.D., Ph.D. Interviewed by Lynne LedermanJeffrey V Ravetch
The Journal of Clinical Investigation|December 19, 2002
A full complement of receptors in immune complex diseasesJeffrey V Ravetch
Current Opinion in Immunology|February 13, 2007
Antibodies, Fc receptors and cancerFalk Nimmerjahn, Jeffrey V Ravetch
Nature Immunology|March 22, 2007
Killing some to make way for othersJeffrey V Ravetch, Michel Nussenzweig
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivoFubin Li, Jeffrey V Ravetch
Advances in Immunology|November 6, 2007
Fc-receptors as regulators of immunityFalk Nimmerjahn, Jeffrey V Ravetch
Immunological Reviews|October 27, 2015
Fcγ receptor pathways during active and passive immunizationStylianos Bournazos, Jeffrey V Ravetch
Cancer Cell|September 14, 2016
Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor EngagementRony Dahan, Jeffrey V Ravetch
Trends in Immunology|January 2, 2007
Opposing effects of Toll-like receptor stimulation induce autoimmunity or toleranceMarc Ehlers, Jeffrey V Ravetch
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Analyzing antibody-Fc-receptor interactionsFalk Nimmerjahn, Jeffrey V Ravetch
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Biotechniques|March 12, 2008
Closing the circle. Jeffrey V. Ravetch, M.D., Ph.D. Interviewed by Lynne LedermanJeffrey V Ravetch
The Journal of Clinical Investigation|December 19, 2002
A full complement of receptors in immune complex diseasesJeffrey V Ravetch
Current Opinion in Immunology|February 13, 2007
Antibodies, Fc receptors and cancerFalk Nimmerjahn, Jeffrey V Ravetch
Nature Immunology|March 22, 2007
Killing some to make way for othersJeffrey V Ravetch, Michel Nussenzweig
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivoFubin Li, Jeffrey V Ravetch
Advances in Immunology|November 6, 2007
Fc-receptors as regulators of immunityFalk Nimmerjahn, Jeffrey V Ravetch
Immunological Reviews|October 27, 2015
Fcγ receptor pathways during active and passive immunizationStylianos Bournazos, Jeffrey V Ravetch
Cancer Cell|September 14, 2016
Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor EngagementRony Dahan, Jeffrey V Ravetch
Trends in Immunology|January 2, 2007
Opposing effects of Toll-like receptor stimulation induce autoimmunity or toleranceMarc Ehlers, Jeffrey V Ravetch
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Analyzing antibody-Fc-receptor interactionsFalk Nimmerjahn, Jeffrey V Ravetch
Pageof 17